annual D&A:
$15.85M+$5.67M(+55.79%)Summary
- As of today (July 3, 2025), PCVX annual depreciation & amortization is $15.85 million, with the most recent change of +$5.67 million (+55.79%) on December 31, 2024.
- During the last 3 years, PCVX annual D&A has risen by +$12.39 million (+358.35%).
- PCVX annual D&A is now at all-time high.
Performance
PCVX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$4.87M+$89.00K(+1.86%)Summary
- As of today (July 3, 2025), PCVX quarterly depreciation & amortization is $4.87 million, with the most recent change of +$89.00 thousand (+1.86%) on March 31, 2025.
- Over the past year, PCVX quarterly D&A has increased by +$1.78 million (+57.68%).
- PCVX quarterly D&A is now at all-time high.
Performance
PCVX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$17.63M+$1.78M(+11.25%)Summary
- As of today (July 3, 2025), PCVX TTM depreciation & amortization is $17.63 million, with the most recent change of +$1.78 million (+11.25%) on March 31, 2025.
- Over the past year, PCVX TTM D&A has increased by +$6.71 million (+61.43%).
- PCVX TTM D&A is now at all-time high.
Performance
PCVX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PCVX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.8% | +57.7% | +61.4% |
| 3 y3 years | +358.4% | +105.7% | +232.7% |
| 5 y5 years | +1186.1% | +1169.3% | +1182.0% |
PCVX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +358.4% | at high | +124.3% | at high | +166.9% |
| 5 y | 5-year | at high | +1186.1% | at high | +1368.1% | at high | +1182.0% |
| alltime | all time | at high | +1428.0% | at high | +1557.8% | at high | +5895.9% |
PCVX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $4.87M(+1.9%) | $17.63M(+11.3%) |
| Dec 2024 | $15.85M(+55.8%) | $4.79M(+6.5%) | $15.85M(+13.1%) |
| Sep 2024 | - | $4.49M(+29.1%) | $14.01M(+16.8%) |
| Jun 2024 | - | $3.48M(+12.5%) | $12.00M(+9.9%) |
| Mar 2024 | - | $3.09M(+4.9%) | $10.92M(+7.4%) |
| Dec 2023 | $10.17M(+7.6%) | $2.95M(+18.9%) | $10.17M(+4.0%) |
| Sep 2023 | - | $2.48M(+3.3%) | $9.78M(+1.3%) |
| Jun 2023 | - | $2.40M(+2.5%) | $9.65M(+2.4%) |
| Mar 2023 | - | $2.34M(-8.4%) | $9.43M(-0.3%) |
| Dec 2022 | $9.45M(+173.4%) | $2.56M(+8.6%) | $9.45M(+16.7%) |
| Sep 2022 | - | $2.35M(+8.3%) | $8.10M(+22.7%) |
| Jun 2022 | - | $2.17M(-8.3%) | $6.60M(+24.6%) |
| Mar 2022 | - | $2.37M(+96.4%) | $5.30M(+53.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $3.46M(+146.0%) | $1.21M(+40.9%) | $3.46M(+33.8%) |
| Sep 2021 | - | $856.00K(-1.4%) | $2.58M(+25.3%) |
| Jun 2021 | - | $868.00K(+64.7%) | $2.06M(+33.1%) |
| Mar 2021 | - | $527.00K(+58.7%) | $1.55M(+10.2%) |
| Dec 2020 | $1.41M(+14.0%) | $332.00K(-0.6%) | $1.41M(0.0%) |
| Sep 2020 | - | $334.00K(-5.9%) | $1.41M(+2.2%) |
| Jun 2020 | - | $355.00K(-7.6%) | $1.38M(+4.0%) |
| Mar 2020 | - | $384.00K(+15.7%) | $1.32M(+7.3%) |
| Dec 2019 | $1.23M(+18.8%) | $332.00K(+9.2%) | $1.23M(+36.9%) |
| Sep 2019 | - | $304.00K(+0.7%) | $900.00K(+51.0%) |
| Jun 2019 | - | $302.00K(+2.7%) | $596.00K(+102.7%) |
| Mar 2019 | - | $294.00K | $294.00K |
| Dec 2018 | $1.04M | - | - |
FAQ
- What is Vaxcyte annual depreciation & amortization?
- What is the all time high annual D&A for Vaxcyte?
- What is Vaxcyte annual D&A year-on-year change?
- What is Vaxcyte quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Vaxcyte?
- What is Vaxcyte quarterly D&A year-on-year change?
- What is Vaxcyte TTM depreciation & amortization?
- What is the all time high TTM D&A for Vaxcyte?
- What is Vaxcyte TTM D&A year-on-year change?
What is Vaxcyte annual depreciation & amortization?
The current annual D&A of PCVX is $15.85M
What is the all time high annual D&A for Vaxcyte?
Vaxcyte all-time high annual depreciation & amortization is $15.85M
What is Vaxcyte annual D&A year-on-year change?
Over the past year, PCVX annual depreciation & amortization has changed by +$5.67M (+55.79%)
What is Vaxcyte quarterly depreciation & amortization?
The current quarterly D&A of PCVX is $4.87M
What is the all time high quarterly D&A for Vaxcyte?
Vaxcyte all-time high quarterly depreciation & amortization is $4.87M
What is Vaxcyte quarterly D&A year-on-year change?
Over the past year, PCVX quarterly depreciation & amortization has changed by +$1.78M (+57.68%)
What is Vaxcyte TTM depreciation & amortization?
The current TTM D&A of PCVX is $17.63M
What is the all time high TTM D&A for Vaxcyte?
Vaxcyte all-time high TTM depreciation & amortization is $17.63M
What is Vaxcyte TTM D&A year-on-year change?
Over the past year, PCVX TTM depreciation & amortization has changed by +$6.71M (+61.43%)